Swiss National Bank - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 93 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$423,000
-52.5%
87,400
+4.3%
0.00%
-100.0%
Q4 2019$891,000
+3.6%
83,800
+1.5%
0.00%0.0%
Q3 2019$860,000
-12.9%
82,600
+28.3%
0.00%0.0%
Q2 2019$987,000
+9.1%
64,400
-8.5%
0.00%0.0%
Q1 2019$905,000
+93.4%
70,400
+42.8%
0.00%0.0%
Q4 2018$468,000
+198.1%
49,300
+540.3%
0.00%0.0%
Q1 2014$157,000
+51.0%
7,700
+45.3%
0.00%
Q4 2013$104,0005,3000.00%
Other shareholders
STEMLINE THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 475,200$6,877,0003.03%
Avoro Capital Advisors LLC 475,000$6,873,0002.64%
VHCP Management, LLC 451,400$6,532,0001.50%
Sio Capital Management, LLC 140,000$2,026,0001.15%
Opus Point Partners Management, LLC 75,000$1,085,0000.91%
Eventide Asset Management 620,200$8,974,0000.68%
Telemetry Investments, L.L.C. 55,000$796,0000.44%
Healthcare Value Capital, LLC 25,000$362,0000.40%
TFS CAPITAL LLC 259,916$3,761,0000.37%
FARALLON CAPITAL MANAGEMENT LLC 672,562$9,732,0000.14%
View complete list of STEMLINE THERAPEUTICS INC shareholders